Cerebrospinal fluid proteomic profiling reveals potential biomarkers and altered pathways in myotonic dystrophy type 1. [PDF]
Zafarullah M +7 more
europepmc +1 more source
Diagnostic odyssey of patients with myotonic dystrophy
James E. Hilbert +8 more
openalex +2 more sources
Aphasia Leading to the Diagnosis of Myotonic Dystrophy Type 1: A Case Report. [PDF]
Maeshima S +4 more
europepmc +1 more source
Simple Repeat-Primed PCR Analysis of the Myotonic Dystrophy Type 1 Gene in a Clinical Diagnostics Environment [PDF]
Philippa Dryland +3 more
openalex +1 more source
Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study. [PDF]
Mul K +26 more
europepmc +1 more source
Pathogenic mechanisms of myotonic dystrophy
Johanna E. Lee, Thomas Cooper
openalex +2 more sources
Evaluation of echocardiography monitoring in myotonic dystrophy type 1 patients. [PDF]
Bovenkerk DSH +11 more
europepmc +1 more source
Fifteen Years of Myotonic Dystrophy Type 1 in Mexico: Clinical, Molecular, and Socioeconomic Insights from a National Reference Cohort. [PDF]
Cerecedo-Zapata CM +12 more
europepmc +1 more source
Cortical thinning and white matter alterations in myotonic dystrophy type 2 over a 10-year period. [PDF]
Krieger B +6 more
europepmc +1 more source
Spectrum of Cancers and Their Prognosis Among Patients With Myotonic Dystrophy.
Gadalla SM +7 more
europepmc +1 more source

